Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Imran Yusuf

MBChB(Hons) MRes MRCP(UK) PG Dip Ed FRCOphth

DPhil Student and MRC Clinical Research Training Fellow

Imran is currently undertaking a DPhil at the University of Oxford under the joint supervision of Professor Robert MacLaren and Professor Peter Charbel Issa. His research focusses on the development of a gene therapy treatment for a currently untreatable form of inherited retinal degeneration which results in blindness.

Imran is an honorary Specialist Registrar in Ophthalmology at the Oxford Eye Hospital, having completed 6 years of ophthalmic surgical training. He graduated from Manchester Medical School in 2009 with Honours, and completed a Masters in Research degree with Distinction. He has published over 40 papers in the peer-reviewed literature, and has won 15 prizes at national or international level including the Duke Elder Prize in Ophthalmology in 2009.

Imran is a co-editor of the first edition of the Oxford Handbook of Medical School (Oxford University Press) scheduled for publication in 2018. He has an interest in medical education having completed a Postgraduate Diploma in Medical Education at the Oxford Learning Institute. He has tutored at Magdalen College, Oxford University for 6 years and has visited Kwale District Eye Centre in Kenya annually over the past 5 years as part of a visiting team to provide clinical skills training and support in clinical research studies.

He is an examiner for the Royal College of Ophthalmologists (RCOphth) and served as the first trainee editor for RCOphth College News. He is part of the RCOphth guideline development group currently making new recommendations for hydroxychloroquine retinopathy screening in the UK, and is leading a national epidemiological study of this disorder. He serves as the UK lead trainee for the UK and Ireland Society of Cataract and Refractive Surgery (UKISCRS).